Greedy Insider · Filing
NRIX · Sell · Hansen Gwenn
Hansen Gwenn (Chief Scientific Officer) sold 1,452 shares of Nurix Therapeutics, Inc. (NRIX) at $26.80, about $39K, on Nov 2, 2026, filed with the SEC on Nov 3, 2026.
Greediness Score 58 · Mixed · high confidence. Describes filing structure, not future returns. Not investment advice.
Primary source: SEC EDGAR · Accession 0001817160-26-000023